www.fdanews.com/articles/133793-astrazeneca-profit-down-5-percent-from-generic-competition-in-us
AstraZeneca Profit Down 5 Percent From Generic Competition in US
January 27, 2011
Competition from generic drugs in the United States contributed to a 5 percent drop in net profit for AstraZeneca PLC in the fourth quarter, the pharmaceutical firm reported Thursday.
StarTribune
StarTribune